Search results
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 4 days agoVaccine makers Moderna and Novavax are hoping for an August rollout this year, earlier than last...
Better Buy: Inovio Pharmaceuticals vs. Novavax | The Motley Fool
The Motley Fool· 2 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of...
COVID’s New ‘FLiRT’ Variants—What To Know As Experts Fear Summer Surge
Forbes· 2 days agoNew coronavirus variants dubbed “FLiRT” are circulating the world and growing dominant in the U.S.,...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA TODAY via Yahoo News· 2 days ago“We don’t yet know if the manufacturers will have patient assistance programs.” Vaccine...
Novavax Sees Unusually Large Options Volume (NASDAQ:NVAX)
ETF DAILY NEWS· 1 day agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) was the target of some unusual options trading activity on Wednesday. Novavax has a 1 year low of $3.53 and ...
The FLiRT COVID variants: What are they and are they more contagious?
Reuters· 52 minutes agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 18 hours agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 7 days agoPer the terms, Sanofi will gain rights to co-market Nuvaxovid globally from next year, except in...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 2 days agoOther vaccine stocks are climbing as well. Shares of CureVac which, like Moderna, develops messenger...
This Stock Just More Than Doubled in 1 Day: Is It a Buy? | The Motley Fool
The Motley Fool· 5 days agoThe biotech has come a long way since its not-so-successful attempt at dominating the coronavirus ...